| Prevalence of steatosis and insulin resistance in patients with chronic hepatitis B compared with chronic hepatitis C and non-alcoholic fatty liver disease R Pais, E Rusu, D Zilisteanu, A Circiumaru, L Micu, M Voiculescu, ... European journal of internal medicine 26 (1), 30-36, 2015 | 69 | 2015 |
| The impact of obesity and metabolic syndrome on chronic hepatitis B and drug-induced liver disease R Pais, E Rusu, V Ratziu Clinics in liver disease 18 (1), 165-178, 2014 | 54 | 2014 |
| Proteomic biomarkers panel: new insights in chronic kidney disease S Mihai, E Codrici, ID Popescu, AM Enciu, E Rusu, D Zilisteanu, ... Disease markers 2016, 2016 | 36 | 2016 |
| Molecular adsorbents recirculating system in patients with severe liver failure. Experience of a single Romanian centre EE Rusu, M Voiculescu, DS Zilisteanu, G Ismail J Gastrointestin Liver Dis 18 (3), 311-316, 2009 | 24 | 2009 |
| Inflammation-related patterns in the clinical staging and severity assessment of chronic kidney disease S Mihai, E Codrici, ID Popescu, AM Enciu, E Rusu, D Zilisteanu, ... Disease markers 2019, 2019 | 19 | 2019 |
| Predictive factors for coronary artery disease among peritoneal dialysis patients without diabetic nephropathy A Andronesi, L Iliuta, M Patruleasa, C Achim, G Ismail, R Bobeica, E Rusu, ... Maedica 7 (3), 227, 2012 | 10 | 2012 |
| Successful application of MARS therapy in a 7 year-old patient with hepatic chronic rejection and severe cholestatic syndrome. M Voiculescu, S Ioanitescu, E Rusu, D Micu, M Mihaila, L Micu Romanian journal of gastroenterology 11 (2), 135-140, 2002 | 10 | 2002 |
| Demographic and Clinical Characteristics of the Full 2015-2018 Cohort of Romanian Fabry Disease Patients S MILITARU, R ADAM, G ISMAIL, E RUSU, A DULĂMEA, R JURCUT Current health sciences journal 45 (3), 272, 2019 | 6 | 2019 |
| Efficacy and safety of triple therapy with MMF, cyclosporine and prednisolone versus cyclosporine and prednisolone in adult patients with idiopathic membranous nephropathy and … R Jurubita, G Ismail, R Bobeica, E Rusu, D Zilisteanu, A Andronesi, ... Nephrology Dialysis Transplantation 27, 186-186, 2012 | 5 | 2012 |
| Systems analyses of the Fabry kidney transcriptome and its response to enzyme replacement therapy identified and cross-validated enzyme replacement therapy-resistant targets … N Delaleu, HP Marti, P Strauss, M Sekulic, T Osman, C Tøndel, R Skrunes, ... Kidney International 104 (4), 803-819, 2023 | 2 | 2023 |
| Nonalcoholic fatty liver disease: a marker of adipose tissue distribution E Caceaune, A Mihai, D Licăroiu, I Copaci, E Rusu, N Caceaune, ... Adipobiology 4, 97-101, 2012 | 2 | 2012 |
| The Impact of Kidney Biopsy for Fabry Nephropathy Evaluation on Patients’ Management and Long-Term Outcomes: Experience of a Single Center EE Rusu, DS Zilisteanu, LM Ciobotaru, M Gherghiceanu, A Procop, ... Biomedicines 10 (7), 1520, 2022 | 1 | 2022 |
| Endocapillary and extracapillary hypercellularity provide different outcomes in IgA nephropathy B Obrisca, R Jurubita, B Sorohan, E Rusu, R Bobeica, A Andronesi, ... NEPHROLOGY DIALYSIS TRANSPLANTATION 33, 87-87, 2018 | 1 | 2018 |
| # 3320 GENETIC TESTING FOR MOLECULAR DIAGNOSIS OF NEPHROLITHIASIS AND NEPHROCALCINOSIS IN ADULT PATIENTS: A SINGLE-CENTER COHORT EE Rusu, AC Lungu, GR Pandele, A Iordache, R Bobeica, LM Ciobotaru, ... Nephrology Dialysis Transplantation 38 (Supplement_1), gfad063c_3320, 2023 | | 2023 |
| # 6391 MARKERS OF SUBCLINICAL LEFT VENTRICULAR DYSFUNCTION ARE ASSOCIATED WITH MORTALITY IN CHRONIC KIDNEY DISEASE PATIENTS WITH PRESERVED EJECTION FRACTION DS Zilisteanu, M Rosca, A Calin, EE Rusu Nephrology Dialysis Transplantation 38 (Supplement_1), gfad063c_6391, 2023 | | 2023 |
| Whole blood transcriptomic profiling in the interpretation of variable phenotype presentation in Fabry disease G Altarescu, O Murik, R Jurcut, EE Rusu, A Mursa, T Mann, ... Molecular Genetics and Metabolism 138 (2), 106998, 2023 | | 2023 |
| Finding the gaps in managing Fabry disease in women: the Romanian experience A Mursa, S Militaru, G Neculae, R Adam, V Radoi, E Rusu, BA Popescu, ... European Heart Journal 43 (Supplement_2), ehac544. 1779, 2022 | | 2022 |
| KIDNEY BIOPSY IN FEMALES WITH FABRY DISEASE IS AN IMPORTANT TOOL TO ESTABLISH THE INDICATION FOR FABRY-SPECIFIC THERAPY EE Rusu, D Zilisteanu, LM Ciobotaru, M Gherghiceanu, R Jurcut, ... NEPHROLOGY DIALYSIS TRANSPLANTATION 37, I13-I14, 2022 | | 2022 |
| INFECTION PROFILE AND ASSOCIATED RISK FACTORS IN AGGRESSIVE GLOMERULONEPHRITIS TREATED WITH INDUCTION AND MAINTENANCE REGIMENS OF IMMUNOSUPPRESSIVE THERAPY A Vornicu, B Obrisca, R Jurubita, AG Andronesi, BM Sorohan, C Achim, ... NEPHROLOGY DIALYSIS TRANSPLANTATION 35, 687-687, 2020 | | 2020 |
| P0380 INFECTION PROFILE AND ASSOCIATED RISK FACTORS IN AGGRESSIVE GLOMERULONEPHRITIS TREATED WITH INDUCTION AND MAINTENANCE REGIMENS OF IMMUNOSUPPRESSIVE THERAPY A Vornicu, B Obrisca, R Jurubita, AG Andronesi, BM Sorohan, C Achim, ... Nephrology Dialysis Transplantation 35 (Supplement_3), gfaa142. P0380, 2020 | | 2020 |
